RecallDepth
Class II Ongoing

Aurobindo Ranitidine Capsules 300 mg, 30-count bottle, Rx Only Distributed by: Aurobindo Pharma USA, Inc. 279 Princeton-Hightstown Road East Windsor, NJ 08520 NDC 59651-145-30

Company
Auromedics Pharma Llc
Recall Initiated
November 6, 2019
Posted
December 4, 2019
Recall Number
D-0528-2020
Voluntary / Mandated
Voluntary: Firm initiated
Quantity
134,160 bottles
Firm Location
East Windsor, NJ, United States

Reason for Recall

CGMP Deviations: N-nitrosodimethylamine (NDMA) has been detected in Ranitidine tablets, capsules and syrups.

Distribution

nationwide

Lot / Code Info

RA3018001-A Jul 2020 RA3018002-A Jul-2020 RA3018003-A Jul 2020 RA3018004-A Aug 2020 RA3018005-A Aug 2020 RA3018006-A Aug 2020 RA3018007-A Sep 2020 RA3018008-A Sep 2020 RA3018009-A Sep 2020 RA3018010-A Oct 2020 RA3019001-A Jan 2021 RA3019002-A Jan 2021 RA3019003-A May 2021

More recalls by Auromedics Pharma Llc

View all recalls by this company →

Other recent Class II Drug recalls